ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of DocGo Inc. (DCGO) Investors and Encourages Investors to Contact the Firm Before December 26, 2023

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) securities during the period from November 8, 2022 through September 17, 2023, inclusive (the “Class Period”). Investors have until December 26, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

On July 30, 2023, the New York Times reported a rocky start to DocGo’s migrant relocation efforts in New York City. The article reported that asylum-seekers have complained of threats and broken promises after New York City awarded DocGo the Relocation Contract. DocGo’s $432 million contract nearly matches the Company’s total 2022 revenue of roughly $441 million. On this news, the price of DocGo shares declined by $0.36, or approximately 4.11%, from $8.75 per share to close at $8.39 on July 31, 2023.

On August 22, 2023, the Albany Times Union reported that the New York Attorney General (“NYAG”) opened an investigation into DocGo and cautioned the Company to cease limiting migrants’ speech or movement. Specifically, the NYAG Civil Rights Bureau sent a letter to DocGo’s attorneys detailing serious concerns it had regarding potential violations of state and federal laws in its handling of the Relocation Contract. Then, on September 6, 2023, New York City Comptroller Brad Lander announced that his office was declining to approve the Relocation Contract. Mayor Adams had the authority to proceed with the Relocation Contract over Comptroller Lander’s objections and ultimately did so. On this news, the price of DocGo shares declined by $0.61 per share, or approximately 7.48%, from $8.16 per share to close at $7.55 on September 6, 2023.

On September 14, 2023, the Albany Times Union published an article reporting that Anthony Capone, DocGo’s Chief Executive Officer, had falsified portions of his professional biography regarding his educational history. Then, on September 15, 2023, DocGo disclosed Capone’s resignation as Chief Executive Officer in a filing with the U.S. Securities and Exchange Commission. On this news, the price of DocGo shares declined by $0.76 per share, or approximately 11.76%, from $6.46 per share to close at $5.70 on September 15, 2023.

Then, on September 18, 2023, Comptroller Lander announced that his office was commencing a real-time audit of operations and invoices incurred by DocGo in connection with the Relocation Contract. Specifically, Comptroller Lander noted that his office has serious concerns about the selection of DocGo as a vendor and the Company’s performance of contract duties. On this news, the price of DocGo shares declined by $0.41 per share, or 7.19%, from $5.70 per share to close at $5.29 on September 18, 2023.

The lawsuit alleges that, throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose that: (i) DocGo’s executive hiring processes were inadequate to fully review and vet the professional and academic backgrounds of job candidates; (ii) the foregoing increased the likelihood of disruptive executive turnover; (iii) contrary to its representations to investors, DocGo had overstated the efficacy of its mobile health and medical transportation services, the very services contemplated by the Relocation Contract; and (iv) all of the foregoing, once revealed, was likely to subject DocGo to significant reputational and/or regulatory scrutiny that would negatively impact the Company’s financial position and/or prospects.

If you purchased or otherwise acquired DocGo securities, have information, or would like to learn more about this lawsuit and how it might affect your rights, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: https://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.